Selected Tag: NATCO Pharma
Selected Tag: NATCO Pharma

The Injection That Replaced Your Doctor With a Dose Chart

As Indian pharma races to launch semaglutide, obesity stops being a disease to prevent and starts looking like a subscription revenue stream.

Krishnadevan V

January 29, 2026 at 2:13 AM IST

Article related image

iStock.com

Market Wrap

Equities Ease on Cautious Tone After GDP Surprise and Rupee Weakness

An end-of-day recap of all that transpired in the Indian markets, highlighting the major price movements and the factors driving them

Dehuti Jani

December 1, 2025 at 12:02 PM IST

Article related image

Natco Pharma gets US FDA Form 483 with seven observations at Chennai API unit

BasisPoint Insight

November 25, 2025 at 10:03 AM IST

Court Unquote

Green crackers, Sahara-SEBI, Digital Arrest, Asian Paints, and more

Your weekly rundown of significant judicial rulings and legal battles influencing policy, companies, regulation, and governance.

BasisPoint Insight

October 20, 2025 at 5:35 AM IST

Article related image

iStock.com

Natco Pharma Shareholders Approve Adcock Ingram Stake Purchase

BasisPoint Insight

October 14, 2025 at 6:00 AM IST

Lupin and Natco Launch Generic Bosentan in US with 180-Day Exclusivity

BasisPoint Insight

August 21, 2025 at 2:44 AM IST

Natco Pharma April-June Net Profit Falls 28% On Year to ₹4.81 Billion

BasisPoint Insight

August 12, 2025 at 10:24 AM IST

NATCO Pharma to Invest ₹41 Billion in South Africa Expansion

BasisPoint Insight

July 25, 2025 at 4:13 AM IST

US FDA Issues 7 Observations To Natco Pharma’s Kothur Unit

BasisPoint Insight

June 20, 2025 at 9:21 AM IST

Natco Pharma Gets One USFDA Observation For Hyderabad API unit

BasisPoint Insight

June 16, 2025 at 9:39 AM IST

Natco Pharma January-March Profit Rises 5% But Misses Estimates; Revenue Up 14%

BasisPoint Insight

May 30, 2025 at 9:08 AM IST

Natco’s Cut-Price Cure Has A Premium Twist

A complex drug priced 99.9% below the original might just lift this stock’s value perception.

Dev Chandrasekhar

April 9, 2025 at 5:26 AM IST

Article related image

iStock.com/Rawf8

Natco Pharma To Price Generic Risdiplam At ₹15,900 In India

BasisPoint Insight

April 8, 2025 at 7:19 AM IST

The Bureau

Duvvuri Subbarao on India’s Growth, Inflation Targeting and Centre–State Faultlines
Learning to Shoot: I Tried to Fly Before I Could Walk
Image